|

Dupilumab Clinical Trials

11 actively recruiting trials across 8 locations

Also known as: DUPIXENT, Dupixent, Dupixent®, REGN668, SAR231893

Filter by location:

Other2 trials

DETACT sEvere asThmAtiC paTients - a Pilot Study

Study to Evaluate Long-term Effectiveness and Safety, Patient Characteristics and Subjective Patient-reported Outcomes of Dupilumab in Patients With Chronic Obstructive Pulmonary Disease (COPD) Under Real-world Conditions

New York, New York2 trials

Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC

Icahn School of Medicine at Mount Sinai

Phase 1/2

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

Mount Sinai Health System

Early 1

Birmingham, Alabama1 trial

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

University of Alabama at Birmingham - School of Medicine- Site Number : 8400003

Phase 4

Cullman, Alabama1 trial

Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

Cullman Research Center- Site Number : 8400001

Phase 4

Phoenix, Arizona1 trial

Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)

Phoenix Children's Hospital- Site Number : 8400001

Phase 3

Scottsdale, Arizona1 trial

Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping

Mayo Clinic

Phase 4

Bakersfield, California1 trial

Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma

Kern Research, Inc

Phase 4

Pittsburgh, Pennsylvania1 trial

Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma

The University of Pittsburgh Asthma Institute at UPMC

Phase 4

San Antonio, Texas1 trial

Dupilumab Effects Against Aeroallergen Challenge

Biogenics Research Chamber

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.